What Sientra does

Sientra is a US-based medical aesthetics company that designs, manufactures, and sells FDA-approved silicone gel breast implants and breast tissue expanders for augmentation and reconstruction procedures. Founded around 2003 and commercially launched in 2012 following FDA approval, the company is operated by Tiger Aesthetics Medical, LLC, headquartered in Conshohocken, Pennsylvania, and trades publicly on NASDAQ under ticker SIEN. The company employs 101-250 people and has accumulated over 600,000 implants in real-world use over 13+ years.

The core product line features proprietary Gel-Shell Integration technology and High-Strength Cohesive (HSC/HSC+) gel across more than 200 implant options in 6 profile levels. Supporting products include the AlloX2 dual-port tissue expander with integrated drain and the Dermaspan soft-shell tissue expander. Sientra markets the industry's only 20-year warranty (Platinum20), covering rupture, capsular contracture, BIA-ALCL, double capsule, and late forming seroma — a differentiator against competitors Mentor, Allergan, and Motiva. Post-market surveillance data shows rupture rates of 0.44% and capsular contracture III/IV rates of 1.09%.

Sientra operates an enterprise field sales motion, selling exclusively through board-certified plastic surgeons in the United States. The company uses a surgeon-locator tool on its website, participates in industry conferences, and maintains a direct sales force targeting surgeon partnerships. Patients cannot purchase directly — they must be referred to a participating board-certified surgeon. Marketing leverages Instagram, LinkedIn, RealSelf (where Sientra holds a 97% Worth It rating as of March 2025), before/after galleries, and patient education resources. Revenue is generated through hardware sales of implants and tissue expanders to surgical providers. The company has raised over $400M across multiple funding rounds between 2007 and 2022, including a $13.2M public offering in October 2022, and has incurred persistent operating losses throughout its public history.

Name

Sientra

Legal name

Tiger Aesthetics Medical, LLC

Website

https://sientra.com

Company type

Public

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Sientra is a US medical aesthetics company that designs, manufactures, and sells FDA-approved silicone gel breast implants and tissue expanders exclusively through board-certified plastic surgeons for breast augmentation and reconstruction, with over 600,000 implants placed since 2012.

Ownership category

akta.pro rank

Product category

Breast Implants and Medical Aesthetic Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

• Breast implants
• Silicone gel implants
• Tissue expanders
• Aesthetic surgery devices
• Breast reconstruction devices

Headquarters

HQ city

Franklin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Silicone Breast Implants: Sale of FDA-approved silicone gel breast implants for breast augmentation and reconstruction. Products are sold exclusively through board-certified plastic surgeons. Revenue is generated through direct sales to surgical providers.
2. Breast Tissue Expanders: Sale of breast tissue expanders including AlloX2 and Dermaspan products for breast reconstruction. These temporary expanders are used prior to permanent implant placement.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Sientra is a medical aesthetics company that develops, manufactures, and sells FDA-approved silicone gel breast implants and breast tissue expanders used in breast augmentation and breast reconstruction procedures. Its products are sold exclusively to and through board-certified plastic surgeons in the United States.

Product overview

Sientra is a medical aesthetics company offering a focused portfolio of FDA-approved breast implants and tissue expanders. The core product line consists of Sientra Silicone Gel Breast Implants with proprietary High-Strength Cohesive (HSC/HSC+) gel technology featuring gel-shell integration, available in over 200 options across 6 profile levels. Supporting the implant business are two tissue expanders: AlloX2 (with integrated drain technology) and Dermaspan (soft-shell design). The company differentiates through its Platinum 20 warranty program—the only 20-year warranty in the industry—and emphasizes safety data with over 600,000 implants in real-world use since 2012.

Differentiator

Problem solved

Functional benefit

Products and services

• Sientra Silicone Gel Breast Implants FDA-approved silicone gel breast implants available in multiple shapes, profiles, projections, and surface textures, used by board-certified plastic surgeons for breast augmentation and revision surgery.
• AlloX2 Breast Tissue Expander Breast tissue expander used in two-stage breast reconstruction procedures to gradually stretch the tissue pocket before placement of a permanent breast implant.
• Dermaspan Breast Tissue Expander Smooth-surface breast tissue expander used in two-stage breast reconstruction to create the tissue pocket for subsequent permanent implant placement.
• OPERA Post-Market Surveillance Study Long-term post-market clinical study collecting safety and effectiveness data on Sientra silicone gel breast implants in real-world use.

Quantifiable outcome

• Rupture rate of 0.44% based on post-market surveillance data from 2012-2025 with over 600,000 implants
• +5 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Reshaping Lives AmericaminorStrategic or Co-development PartnerCharitable partnership supporting Reshaping Lives: Full Circle program that provides no-cost breast reconstructive surgery for post-mastectomy women living in poverty in the United States. Sientra participates as a product donor supporting the initiative.
• Tiger Aesthetics Medical, LLCcoreOthersTiger Aesthetics Medical, LLC is the parent company and manufacturer of Sientra breast implants. The company is headquartered in Conshohocken, PA and operates under the Tiger Aesthetics brand.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Mentor (Johnson & Johnson MedTech): Mentor is the US market leader in breast implants (MemoryGel, MemoryShape) and a direct competitor to Sientra with a similar surgeon-channel sales model and FDA-approved silicone gel portfolio.
• Allergan Aesthetics (AbbVie) – Natrelle: Allergan's Natrelle line is one of the largest silicone and saline breast implant brands globally, sold through plastic surgeons with comparable warranty programs, directly competing with Sientra in the US channel.
• Establishment Labs (Motiva): Establishment Labs manufactures Motiva breast implants with SmoothSilk/SilkSurface technologies and is expanding in the US. Comparable cohesive gel and surface technology positioning make it a direct peer to Sientra.
• GC Aesthetics: GC Aesthetics is an established global breast implant manufacturer (Eurosilicone, Nagor, PERLE). Comparable silicone gel and shaped implant portfolio serving plastic surgeons internationally.
• Polytech Health & Aesthetics: Polytech manufactures silicone gel breast implants (MESMO, Replicon) and tissue expanders (CPX4) primarily outside the US, with similar surgeon-channel GTM and a comparable product mix including expanders.

Emerging players

• Ideal Implant: Ideal Implant developed a structured saline breast implant sold through board-certified plastic surgeons in the US. Smaller scale but overlapping customer base and surgeon distribution channel.

Regional players

• Sebbin: Sebbin is a French manufacturer of silicone gel breast implants and expanders primarily serving European and select international markets. Comparable product line with limited direct US overlap but directly comparable implants.

Broad incumbents

• Allergan (AbbVie) – LATISSE / SkinMedica aesthetics portfolio: While broader than breast implants, Allergan/AbbVie's aesthetics franchise provides context on a large incumbent operating in the same plastic surgeon channel that Sientra depends on.
• Tissue Expander Adjacent – Stryker: Stryker's medical division manufactures surgical implants and reconstruction-related devices, providing a broader incumbent benchmark for the reconstructive surgery segment where Sientra's expanders compete.

Others

• RealSelf: RealSelf is the patient review and surgeon-discovery platform that drives Sientra's consumer demand engine (97% Worth It rating). It is a key channel partner rather than a competitor, included as an ecosystem enabler.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/sientrainc
• Instagraminstagram.com/sientra_official
• Xx.com/sientrainc
• Facebookfacebook.com/SientraInc

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds8 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sientra